Post-earnings recap
Reported
Mon, Oct 28, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp's strong EPS performance indicates better-than-expected profitability, which likely contributed to the slight increase in stock price. Investors may view this as a positive sign of the company's financial health, despite the lack of revenue data and future guidance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.66 | N/A | +16.81% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting their commitment to operational efficiency. However, they did not provide specific guidance for future quarters.
We are pleased with our EPS performance this quarter.
We are focused on maintaining our operational efficiency.